↓ Skip to main content

Selective Inhibition of Regulatory T Cells by Targeting the PI3K–Akt Pathway

Overview of attention for article published in Cancer Immunology Research, November 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 X users

Citations

dimensions_citation
126 Dimensions

Readers on

mendeley
113 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Selective Inhibition of Regulatory T Cells by Targeting the PI3K–Akt Pathway
Published in
Cancer Immunology Research, November 2014
DOI 10.1158/2326-6066.cir-14-0095
Pubmed ID
Authors

Rasha Abu-Eid, Raed N. Samara, Laurent Ozbun, Maher Y. Abdalla, Jay A. Berzofsky, Kevin M. Friedman, Mikayel Mkrtichyan, Samir N. Khleif

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 113 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
United States 1 <1%
Unknown 111 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 29 26%
Researcher 20 18%
Other 10 9%
Student > Master 10 9%
Student > Bachelor 9 8%
Other 13 12%
Unknown 22 19%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 24 21%
Agricultural and Biological Sciences 22 19%
Medicine and Dentistry 18 16%
Immunology and Microbiology 14 12%
Pharmacology, Toxicology and Pharmaceutical Science 5 4%
Other 5 4%
Unknown 25 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 February 2024.
All research outputs
#16,698,218
of 25,347,437 outputs
Outputs from Cancer Immunology Research
#1,215
of 1,524 outputs
Outputs of similar age
#152,341
of 268,926 outputs
Outputs of similar age from Cancer Immunology Research
#19
of 23 outputs
Altmetric has tracked 25,347,437 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,524 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.1. This one is in the 18th percentile – i.e., 18% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 268,926 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.